Transdermal Fentanyl in Opioid-Naive Cancer Pain Patients: An Open Trial Using Transdermal Fentanyl for the Treatment of Chronic Cancer Pain in Opioid-Naive Patients and a Group Using Codeine
- 31 March 2000
- journal article
- clinical trial
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 19 (3) , 185-192
- https://doi.org/10.1016/s0885-3924(99)00152-9
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine.Journal of Clinical Oncology, 1998
- Long-Term Treatment of Cancer Pain With Transdermal FentanylJournal of Pain and Symptom Management, 1998
- Transdermal fentanyl versussustained-release oral morphine in cancer pain: Preference, efficacy, and quality of lifeJournal of Pain and Symptom Management, 1997
- Transdermal fentanyl therapy: system design, pharmacokinetics and efficacyAnti-Cancer Drugs, 1995
- Transdermal fentanyl: a new step on the therapeutic ladderAnti-Cancer Drugs, 1995
- Transdermal fentanyl: Clinical pharmacologyJournal of Pain and Symptom Management, 1992